戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  (19 Whipple, four total pancreatectomy, one distal pancreatectomy).
2 ain removal has yet to be explored following distal pancreatectomy.
3 undergoing either pancreaticoduodenectomy or distal pancreatectomy.
4 tal stay, and recovery as compared with open distal pancreatectomy.
5 aticoduodenectomy and 257 +/- 93 minutes for distal pancreatectomy.
6 erence in SSI between antibiotic-types after distal pancreatectomy.
7 resection such as pancreaticoduodenectomy or distal pancreatectomy.
8 my, 22% via total pancreatectomy, and 8% via distal pancreatectomy.
9 g the current indications and outcomes after distal pancreatectomy.
10 e largest single-institution experience with distal pancreatectomy.
11 dications, complications, and outcomes after distal pancreatectomy.
12  patients underwent pancreatoduodenectomy or distal pancreatectomy.
13 ients in groups 2A and 2B, 24% and 58% had a distal pancreatectomy, 0% and 13% had a hepatic resectio
14 on rate (3-8%) when compared to laparoscopic distal pancreatectomy (10-20%).
15 6%) (11 with pancreaticoduodenectomy, 2 with distal pancreatectomy, 2 with central pancreatectomy, 1
16           Fourteen underwent an operation (6 distal pancreatectomy, 4 total pancreatectomy, and 4 pan
17                                              Distal pancreatectomy (40%), enucleation (34%), and panc
18  0.25 to 0.95) and 80 patients who underwent distal pancreatectomy (7% vs. 23%; relative risk, 0.32;
19                                          For distal pancreatectomies (7085 patients; 6.2% mortality),
20 ere analyzed; pancreaticoduodenectomy (132), distal pancreatectomy (83), central pancreatectomy (13),
21 ational level, this projected to 42,320 open distal pancreatectomies and 1908 MIDPs.
22 dvanced surgical procedures such as combined distal pancreatectomy and left nephrectomy can be safely
23  present the first reported combined robotic distal pancreatectomy and left nephrectomy from a live d
24     Findings differed between fistulas after distal pancreatectomy and pancreatoduodenectomy.
25 pancreaticoduodenectomy, and 1 patient had a distal pancreatectomy and splenectomy.
26 res included 9 pancreaticoduodenectomies, 10 distal pancreatectomies, and 1 total pancreatectomy; 21
27 ies, 113 partial pancreatoduodenectomies, 79 distal pancreatectomies, and 10 resections for tumor rec
28 erwent total pancreatectomies, 10% underwent distal pancreatectomies, and 3% underwent distal subtota
29 ) underwent 541 pancreatoduodenectomies, 285 distal pancreatectomies, and 6 other pancreatectomies.
30 Two patients had total pancreatectomy, 2 had distal pancreatectomy, and the remaining had pancreatico
31 sections, including pancreaticoduodenectomy, distal pancreatectomy, and total pancreatectomy, remain
32 -preserving from 29 high-volume centers ( 15 distal pancreatectomies annually) in 8 European countrie
33 preserving from 29 high-volume centers (>=15 distal pancreatectomies annually) in 8 European countrie
34 8 countries that each performed more than 15 distal pancreatectomies annually, with an overall experi
35                  Pancreaticoduodenectomy and distal pancreatectomy are associated with significant pe
36 ospective analysis of all minimally invasive distal pancreatectomies at University of Pittsburgh Medi
37 ctive review of 721 patients who underwent a distal pancreatectomy between February 1986 and February
38  hospital records of all patients undergoing distal pancreatectomy between January 1994 and December
39 crine pancreatic insufficiency compared with distal pancreatectomy but it is thought to increase the
40                   Spleen preservation during distal pancreatectomy can be achieved by either preserva
41 trate that, as with pancreaticoduodenectomy, distal pancreatectomy can be performed with minimal peri
42 ve outcomes and hospital charge measures for distal pancreatectomy, comparing the surgical approaches
43  risk-adjusted in-hospital mortality for all distal pancreatectomies (DP), pancreatoduodenectomies (W
44 the development of PL in patients undergoing distal pancreatectomy (DP) at a single high-volume insti
45  who underwent pancreatoduodenectomy (PD) or distal pancreatectomy (DP) for all indications between 2
46 h nodes (ELNs) on staging and survival after distal pancreatectomy (DP) for pancreatic adenocarcinoma
47 evant pancreatic fistula (CR-POPF) following distal pancreatectomy (DP) is a dominant contributor to
48 true rate of new-onset diabetes (NODM) after distal pancreatectomy (DP) is not known.
49 al level, the early and long-term outcome of distal pancreatectomy (DP) performed by laparoscopy (Lap
50 f this study was to test the hypothesis that distal pancreatectomy (DP) without intraperitoneal drain
51  clinically relevant fistula (CR-POPF) after distal pancreatectomy (DP), and to identify the cut-off
52 ts undergoing pancreatoduodenectomy (PD) and distal pancreatectomy (DP), and to quantify the delivery
53 nt covering on pancreatic fistula rate after distal pancreatectomy (DP).
54 enectomy (PD, n = 218), central (n = 16), or distal pancreatectomy (DP, n = 96).
55 es (124 modified Puestow procedure [LPJ], 29 distal pancreatectomies [DP], and 46 pancreatic head res
56 analysis of a retrospective cohort including distal pancreatectomies for PDAC from 34 centers in 11 c
57                                   Among 1212 distal pancreatectomies for PDAC, 345 patients underwent
58 o underwent elective laparoscopic or robotic distal pancreatectomy for all indications were included.
59 ts undergoing laparoscopic spleen-preserving distal pancreatectomy for benign or low-grade malignant
60 who underwent laparoscopic spleen-preserving distal pancreatectomy for benign or lowgrade malignant t
61 stomosis during pancreaticoduodenectomy; and distal pancreatectomy for benign/borderline neoplasm of
62 aroscopic sleeve gastrectomy to 6.8% in open distal pancreatectomy for cancer.
63                                              Distal pancreatectomy for chronic pancreatitis from any
64  A personal series of 90 patients undergoing distal pancreatectomy for chronic pancreatitis over the
65    CP is a parenchyma-sparing alternative to distal pancreatectomy for symptomatic benign and premali
66  factors, among patients undergoing elective distal pancreatectomy from 1998 to 2009 in the Nationwid
67 junostomy, cholecystectomy, splenectomy, and distal pancreatectomy have been performed successfully v
68 Superior outcomes of MIDP compared with open distal pancreatectomy have been reported.
69 1% of patients, total pancreatectomy in 15%, distal pancreatectomy in 12%, and central pancreatic res
70 enectomy was performed in 139 patients and a distal pancreatectomy in 40 cases.
71 gly performed as an alternative approach for distal pancreatectomy in selected patients.
72         Three patients underwent noncurative distal pancreatectomy in the early period.
73  of the pancreatic head in this disease, but distal pancreatectomy is a less popular option attended
74         These data demonstrate that elective distal pancreatectomy is associated with a mortality rat
75 idely implemented, early drain removal after distal pancreatectomy is associated with better outcomes
76                                              Distal pancreatectomy is performed for a variety of beni
77                                              Distal pancreatectomy is the standard procedure for remo
78                                 Laparoscopic distal pancreatectomy (LDP) reduces postoperative morbid
79 al 9 men and 16 women underwent laparoscopic distal pancreatectomy (LDP) using a technique similar to
80        The clinical pathway for laparoscopic distal pancreatectomy (LDP) versus open (ODP) for nonmal
81 ase selection factors for minimally invasive distal pancreatectomy (MIDP) and identify actual risk fa
82 utcomes of open (ODP) and minimally invasive distal pancreatectomy (MIDP) are equivalent for benign l
83  on the learning curve of minimally invasive distal pancreatectomy (MIDP) are mostly small, single-ce
84 pact of conversion during minimally invasive distal pancreatectomy (MIDP) for pancreatic ductal adeno
85               Interest in minimally invasive distal pancreatectomy (MIDP) has grown in recent years,
86 ncological outcomes after minimally invasive distal pancreatectomy (MIDP) with open distal pancreatec
87 nwide training program in minimally invasive distal pancreatectomy (MIDP), according to the IDEAL fra
88 r to pancreatoduodenectomy (n = 514; 88.2%), distal pancreatectomy (n = 62; 10.6%), or total pancreat
89 y (n=50), Whipple or Beger procedure (n=14), distal pancreatectomy (n=8), or lateral pancreaticojejun
90 asive distal pancreatectomy (MIDP) with open distal pancreatectomy (ODP) in patients with pancreatic
91 duce the treatment burden compared with open distal pancreatectomy (ODP), but studies on institutiona
92 l recovery after minimally invasive and open distal pancreatectomy (ODP).
93 tors for adverse outcomes compared with open distal pancreatectomy (ODP).
94 by a propensity-matched comparison with open distal pancreatectomy (ODP).
95 gher islet yield compared with those who had distal pancreatectomy or lateral pancreaticojejunostomy.
96 liver disease (OR, 2.28; 95% CI, 1.23-4.24), distal pancreatectomy (OR, 1.77; 95% CI, 1.11-2.84), and
97 mortality), there were 2 cut-offs (13 and 25 distal pancreatectomies per year), but neither was an in
98                            The proportion of distal pancreatectomies performed via minimally invasive
99 tients undergoing pancreaticoduodenectomy or distal pancreatectomy [POPF: pasireotide (n = 152), 9% v
100          We hypothesized that robot-assisted distal pancreatectomy (RADP) was superior to LDP as a re
101 ent phases of the learning curve for robotic distal pancreatectomy (RDP) in international expert cent
102 that reinforcement of stapled closure during distal pancreatectomy reduces the rate of fistula format
103 -one of 36 patients who failed to respond to distal pancreatectomy required further intervention, inc
104 ogic examination of five patients undergoing distal pancreatectomy revealed striking changes of advan
105 sequences on clinical outcomes after robotic distal pancreatectomy (RPD).
106 ecrosis, definitive surgical management with distal pancreatectomy should be undertaken in patients w
107 g a training program to teach robot-assisted distal pancreatectomy to surgeons at an academic institu
108 associated with mortality ranging from 7.3% (distal pancreatectomy) to 22.9% (total pancreatectomy).
109                           Minimally invasive distal pancreatectomy was performed increasingly in late
110               Post-PCD surgery (necrosectomy distal pancreatectomy) was needed in 50% of ANC and 25%
111 n the Netherlands (2005 to 2013) only 10% of distal pancreatectomies were in a minimally invasive fas
112                              A total of 8957 distal pancreatectomies were included in this analysis,
113  often requires a pancreatoduodenectomy or a distal pancreatectomy with or without a splenectomy.
114                     Patients who underwent a distal pancreatectomy with splenectomy (n = 198) had a s

 
Page Top